Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

PHARMAC To Buy Drugs For Hospitals

The Government’s pharmaceutical-buying agency PHARMAC has just announced that it will be working with District Health Boards round the country to help them purchase drugs for their hospitals.

PHARMAC Chief Executive Wayne McNee says the agency will be working collaboratively with the District Health Boards to work out what their drug purchasing needs are.

He says PHARMAC’s role in hospitals will be different from its current role in managing pharmaceutical expenditure in the community. However, PHARMAC is confident that many of the strategies it has successfully used over the past eight years will work in the hospital sector.

Currently, most individual District Health Boards negotiate with pharmaceutical companies for the drugs they use.

“We can see variations in the price of the same drug in different hospitals around the country. We think there is room for savings to be made by implementing a sensible national strategy,” says Wayne McNee.

PHARMAC was set up in 1993 to manage drug subsidies for medicines available in the community.

“New Zealand’s growth in spending on pharmaceutical subsidies outside the hospital sector has averaged three per cent a year over the past seven years. Before PHARMAC was set up, the growth in spending had been as high as twenty percent.

“New Zealand has a finite health budget and our job is to try to make those health dollars go further.”

Wayne McNee says the battle to keep pharmaceuticals affordable, is the same internationally. Australia has just reported that its drug subsidy system has had a budget blow-out of 22 percent and the United States’ spending on prescription drugs increased by nearly 19 percent in 2000.

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

“In New Zealand we have been successful in keeping down the price of drugs, at the same time achieving the best health care we can within the funding available. It is this successful formula we will now be working on with the hospital sector.”

Wayne McNee says the bill to the taxpayer for drug subsidies on community medicines is between $530 and $540 million. Hospitals spend an estimated $100 million to $140 million in total.

“We will be looking at where we can make savings to help them manage their budgets.”

[ends]

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
 
 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.